English  |  正體中文  |  简体中文  |  总笔数 :2823024  
造访人次 :  30232097    在线人数 :  465
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"wang f d"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 31-67 / 67 (共2页)
1 2 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
國立成功大學 2021 Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019–2020 Nationwide Surveillance of Multicenter Antimicrobial Resist Tsai, H.-Y.;Lee, Y.-L.;Liu, P.-Y.;Lu, M.-C.;Shao, P.-L.;Lu, P.-L.;Cheng, S.-H.;Ko, W.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Lee, W.-S.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Chen, Y.-H.;Liao, C.-H.;Hsueh, P.-R.
國立成功大學 2021 National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Chien, Y.-C.;Lee, Y.-L.;Liu, P.-Y.;Lu, M.-C.;Shao, P.-L.;Lu, P.-L.;Cheng, S.-H.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Lee, W.-S.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Chen, Y.-H.;Ko, W.-C.;Hsueh, P.-R.
國立成功大學 2021 In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistan Lee, Y.-L.;Ko, W.-C.;Lee, W.-S.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Lu, M.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Shao, P.-L.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Hsueh, P.-R.
臺大學術典藏 2020-12-29T03:48:03Z Clinical outcomes and prognostic factors of patients with severe influenza receiving intravenous peramivir salvage therapy in intensive care units Yeh C.-Y.;Wang F.-D.;Yu-Chung Chuang;Yang C.-J.;Huang S.-F.;Weng W.-S.;Liaw C.-H.;Sheng W.-H.; Yeh C.-Y.; Wang F.-D.; YU-CHUNG CHUANG; Yang C.-J.; Huang S.-F.; Weng W.-S.; Liaw C.-H.; Sheng W.-H.
臺大學術典藏 2020-12-18T08:37:40Z Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan Wang F.D.;Liao C.H.;Lin Y.T.;Sheng W.H.;Po-Ren Hsueh; Wang F.D.; Liao C.H.; Lin Y.T.; Sheng W.H.; PO-REN HSUEH
臺大學術典藏 2020-12-18T08:37:10Z In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) Jean S.-S.;Lu M.-C.;Shi Z.-Y.;Tseng S.-H.;Wu T.-S.;Lu P.-L.;Shao P.-L.;Ko W.-C.;Wang F.-D.;Po-Ren Hsueh; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH
臺大學術典藏 2020-12-18T08:36:57Z Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018 Chen Y.-H.; Sheng W.-H.; Lee C.-M.; Liao M.-H.; PO-REN HSUEH; Lee Y.-L.;Lu M.-C.;Shao P.-L.;Lu P.-L.;Chen Y.-H.;Cheng S.-H.;Ko W.-C.;Lin C.-Y.;Wu T.-S.;Yen M.-Y.;Wang L.-S.;Liu C.-P.;Lee W.-S.;Shi Z.-Y.;Chen Y.-S.;Wang F.-D.;Tseng S.-H.;Lin C.-N.;Chen Y.-H.;Sheng W.-H.;Lee C.-M.;Liao M.-H.;Po-Ren Hsueh; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.
臺大學術典藏 2020-12-18T08:36:52Z Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016 Kuo S.-C.;Liu C.-E.;Lu P.-L.;Chen Y.-S.;Lu M.-C.;Ko W.-C.;Po-Ren Hsueh;Chuang Y.-C.;Wang F.-D.;The Smart Asia-Pacific Group; Kuo S.-C.; Liu C.-E.; Lu P.-L.; Chen Y.-S.; Lu M.-C.; Ko W.-C.; PO-REN HSUEH; Chuang Y.-C.; Wang F.-D.; the SMART Asia-Pacific Group
臺大學術典藏 2020-12-18T08:36:44Z National surveillance of antimicrobial susceptibility of bacteremic gram-negative bacteria with emphasis on community-acquired resistant isolates: Report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) Wang F.-D.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Chen Y.-S.; Lin C.-Y.; Ko W.-C.; Cheng S.-H.; Chen Y.-H.; Lu P.-L.; Shao P.-L.; Lu M.-C.; Lee Y.-L.; Liu P.-Y.;Lee Y.-L.;Lu M.-C.;Shao P.-L.;Lu P.-L.;Chen Y.-H.;Cheng S.-H.;Ko W.-C.;Lin C.-Y.;Wu T.-S.;Yen M.-Y.;Wang L.-S.;Liu C.-P.;Lee W.-S.;Chen Y.-S.;Wang F.-D.;Tseng S.-H.;Lin C.-N.;Tang H.-J.;Chen Y.-H.;Sheng W.-H.;Lee C.-M.;Liao M.-H.;Po-Ren Hsueh; Liu P.-Y.; Tseng S.-H.; Lin C.-N.; Tang H.-J.; Chen Y.-H.; Sheng W.-H.; Lee C.-M.; Liao M.-H.; PO-REN HSUEH
臺大學術典藏 2020-11-04T09:17:02Z Cohort selection for clinical trials using multiple instance learning Dai H.-J.; Wang F.-D.; Chen C.-W.; Su C.-H.; CHI-SHIN WU; Jonnagaddala J.
臺大學術典藏 2020-09-29T01:47:32Z Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan? Lu P.-L.; Liu W.-L.; Lo H.-J.; Wang F.-D.; Ko W.-C.; Hsueh P.-R.; Ho M.-W.; Liu C.-E.; Chen Y.-H.; YEE-CHUN CHEN; Chuang Y.-C.; Chang S.-C.
臺大學術典藏 2020-06-30T06:13:30Z Consensus Statement on the Adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in Clinical Microbiology Laboratories in Taiwan Hsueh P.-R.;Ko W.-C.;Wu J.-J.;Lu J.-J.;Wang F.-D.;Wu H.-Y.;Wu T.-L.;Lee-Jene Teng; Hsueh P.-R.; Ko W.-C.; Wu J.-J.; Lu J.-J.; Wang F.-D.; Wu H.-Y.; Wu T.-L.; LEE-JENE TENG
臺大學術典藏 2020-06-30T06:13:30Z Consensus Statement on the Adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in Clinical Microbiology Laboratories in Taiwan Hsueh P.-R.;Ko W.-C.;Wu J.-J.;Lu J.-J.;Wang F.-D.;Wu H.-Y.;Wu T.-L.;Lee-Jene Teng; Hsueh P.-R.; Ko W.-C.; Wu J.-J.; Lu J.-J.; Wang F.-D.; Wu H.-Y.; Wu T.-L.; LEE-JENE TENG
臺大學術典藏 2020-03-27T05:29:51Z Consensus Statement on the Adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in Clinical Microbiology Laboratories in Taiwan Teng L.-J.; Wu T.-L.; Wu H.-Y.; Wang F.-D.; Lu J.-J.; Wu J.-J.; Ko W.-C.; Teng L.-J.;Wu T.-L.;Wu H.-Y.;Wang F.-D.;Lu J.-J.;Wu J.-J.;Ko W.-C.;PO-REN HSUEH; PO-REN HSUEH
臺大學術典藏 2020-03-27T05:29:51Z Consensus Statement on the Adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in Clinical Microbiology Laboratories in Taiwan Teng L.-J.; Wu T.-L.; Wu H.-Y.; Wang F.-D.; Lu J.-J.; Wu J.-J.; Ko W.-C.; Teng L.-J.;Wu T.-L.;Wu H.-Y.;Wang F.-D.;Lu J.-J.;Wu J.-J.;Ko W.-C.;PO-REN HSUEH; PO-REN HSUEH
臺大學術典藏 2020-03-27T05:29:01Z Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan PO-REN HSUEH;Sheng W.H.;Lin Y.T.;Liao C.H.;Wang F.D.; Wang F.D.; Liao C.H.; Lin Y.T.; Sheng W.H.; PO-REN HSUEH
臺大學術典藏 2020-03-27T05:29:01Z Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008–2012, northern Taiwan PO-REN HSUEH;Sheng W.H.;Lin Y.T.;Liao C.H.;Wang F.D.; Wang F.D.; Liao C.H.; Lin Y.T.; Sheng W.H.; PO-REN HSUEH
臺大學術典藏 2020-03-27T05:28:35Z In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) PO-REN HSUEH;Wang F.-D.;Ko W.-C.;Shao P.-L.;Lu P.-L.;Wu T.-S.;Tseng S.-H.;Shi Z.-Y.;Lu M.-C.;Jean S.-S.; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH
臺大學術典藏 2020-03-27T05:28:35Z In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) PO-REN HSUEH;Wang F.-D.;Ko W.-C.;Shao P.-L.;Lu P.-L.;Wu T.-S.;Tseng S.-H.;Shi Z.-Y.;Lu M.-C.;Jean S.-S.; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH
臺大學術典藏 2020-03-27T05:28:29Z Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan Wang L.-S.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH; Infection Control Society of Taiwan; Infection Control Society of Taiwan;PO-REN HSUEH;Wang F.-D.;Ko W.-C.;Chen Y.-H.;Lin C.-N.;Tseng S.-H.;Wang L.-S.;Chen Y.-S.;Shi Z.-Y.;Lu M.-C.;Lin Y.-T.;Lin Y.-T.;Lai C.-C.; Lai C.-C.; Lin Y.-T.; Lin Y.-T.; Lu M.-C.; Shi Z.-Y.; Chen Y.-S.
臺大學術典藏 2020-03-27T05:28:29Z Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan Wang L.-S.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH; Infection Control Society of Taiwan; Infection Control Society of Taiwan;PO-REN HSUEH;Wang F.-D.;Ko W.-C.;Chen Y.-H.;Lin C.-N.;Tseng S.-H.;Wang L.-S.;Chen Y.-S.;Shi Z.-Y.;Lu M.-C.;Lin Y.-T.;Lin Y.-T.;Lai C.-C.; Lai C.-C.; Lin Y.-T.; Lin Y.-T.; Lu M.-C.; Shi Z.-Y.; Chen Y.-S.
臺大學術典藏 2020-03-27T05:28:19Z Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016 the SMART Asia-Pacific Group; Wang F.-D.; Ko W.-C.; PO-REN HSUEH; Chuang Y.-C.; the SMART Asia-Pacific Group;Wang F.-D.;Chuang Y.-C.;PO-REN HSUEH;Ko W.-C.;Lu M.-C.;Chen Y.-S.;Lu P.-L.;Liu C.-E.;Kuo S.-C.; Kuo S.-C.; Liu C.-E.; Lu P.-L.; Chen Y.-S.; Lu M.-C.
臺大學術典藏 2020-03-27T05:28:19Z Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016 the SMART Asia-Pacific Group; Wang F.-D.; Ko W.-C.; PO-REN HSUEH; Chuang Y.-C.; the SMART Asia-Pacific Group;Wang F.-D.;Chuang Y.-C.;PO-REN HSUEH;Ko W.-C.;Lu M.-C.;Chen Y.-S.;Lu P.-L.;Liu C.-E.;Kuo S.-C.; Kuo S.-C.; Liu C.-E.; Lu P.-L.; Chen Y.-S.; Lu M.-C.
國立成功大學 2020 National surveillance of antimicrobial susceptibility of bacteremic gram-negative bacteria with emphasis on community-acquired resistant isolates: Report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) Liu, P.-Y.;Lee, Y.-L.;Lu, M.-C.;Shao, P.-L.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Ko, W.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Lee, W.-S.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Tang, H.-J.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Liao, M.-H.;Hsueh, P.-R.
國立成功大學 2020 Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016 Kuo, S.-C.;Liu, C.-E.;Lu, P.-L.;Chen, Y.-S.;Lu, M.-C.;Ko, W.-C.;Hsueh, P.-R.;Chuang, Y.-C.;Wang, F.-D.;Group, the SMART Asia-Pacific
臺大學術典藏 2019 Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018 PO-REN HSUEH; Liao M.-H.; PO-REN HSUEH;Liao M.-H.;Lee C.-M.;Sheng W.-H.;Chen Y.-H.;Lin C.-N.;Tseng S.-H.;Wang F.-D.;Chen Y.-S.;Shi Z.-Y.;Lee W.-S.;Liu C.-P.;Wang L.-S.;Yen M.-Y.;Wu T.-S.;Lin C.-Y.;Ko W.-C.;Cheng S.-H.;Chen Y.-H.;Lu P.-L.;Shao P.-L.;Lu M.-C.;Lee Y.-L.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; Sheng W.-H.; Lee C.-M.
臺大學術典藏 2019 Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018 PO-REN HSUEH; Liao M.-H.; PO-REN HSUEH;Liao M.-H.;Lee C.-M.;Sheng W.-H.;Chen Y.-H.;Lin C.-N.;Tseng S.-H.;Wang F.-D.;Chen Y.-S.;Shi Z.-Y.;Lee W.-S.;Liu C.-P.;Wang L.-S.;Yen M.-Y.;Wu T.-S.;Lin C.-Y.;Ko W.-C.;Cheng S.-H.;Chen Y.-H.;Lu P.-L.;Shao P.-L.;Lu M.-C.;Lee Y.-L.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; Sheng W.-H.; Lee C.-M.
國立成功大學 2019 Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018 Lee, Y.-L.;Lu, M.-C.;Shao, P.-L.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Ko, W.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Lee, W.-S.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Liao, M.-H.;Hsueh, P.-R.
臺大學術典藏 2018 Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan? Chang S.-C.; Chuang Y.-C.; Chen Y.-H.; Chen Y.-C.; Liu C.-E.; Ho M.-W.; PO-REN HSUEH; Ko W.-C.; Wang F.-D.; Lo H.-J.; Liu W.-L.; Lu P.-L.; Chang S.-C.;Chuang Y.-C.;Chen Y.-C.;Chen Y.-H.;Liu C.-E.;Ho M.-W.;PO-REN HSUEH;Ko W.-C.;Wang F.-D.;Lo H.-J.;Liu W.-L.;Lu P.-L.
臺大學術典藏 2018 Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan? Chang S.-C.; Chuang Y.-C.; Chen Y.-H.; Chen Y.-C.; Liu C.-E.; Ho M.-W.; PO-REN HSUEH; Ko W.-C.; Wang F.-D.; Lo H.-J.; Liu W.-L.; Lu P.-L.; Chang S.-C.;Chuang Y.-C.;Chen Y.-C.;Chen Y.-H.;Liu C.-E.;Ho M.-W.;PO-REN HSUEH;Ko W.-C.;Wang F.-D.;Lo H.-J.;Liu W.-L.;Lu P.-L.
臺大學術典藏 2018 Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan Lai C.-C.;Lin Y.-T.;Lin Y.-T.;Lu M.-C.;Shi Z.-Y.;Chen Y.-S.;Wang L.-S.;Tseng S.-H.;Lin C.-N.;Chen Y.-H.;Ko W.-C.;Wang F.-D.;Po-Ren Hsueh;Infection Control Society Of Taiwan; Chen Y.-H.; Lin C.-N.; Tseng S.-H.; Lai C.-C.; Lin Y.-T.; Lin Y.-T.; Lu M.-C.; Shi Z.-Y.; Chen Y.-S.; Wang L.-S.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH; Infection Control Society of Taiwan
臺大學術典藏 2018 Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan? Lu P.-L.; Lu P.-L.;Liu W.-L.;Lo H.-J.;Wang F.-D.;Ko W.-C.;Po-Ren Hsueh;Ho M.-W.;Liu C.-E.;Chen Y.-H.;Chen Y.-C.;Chuang Y.-C.;Chang S.-C.; Chang S.-C.; Liu W.-L.; Lo H.-J.; Wang F.-D.; Ko W.-C.; PO-REN HSUEH; Ho M.-W.; Liu C.-E.; Chen Y.-H.; Chen Y.-C.; Chuang Y.-C.
臺大學術典藏 2018 Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan? Wang F.-D.; Liu W.-L.; Lo H.-J.; Lu P.-L.; Lu P.-L.;Liu W.-L.;Lo H.-J.;Wang F.-D.;Ko W.-C.;Hsueh P.-R.;Ho M.-W.;Liu C.-E.;Chen Y.-H.;Chen Y.-C.;Chuang Y.-C.;Shan-Chwen Chang; Ko W.-C.; Hsueh P.-R.; Ho M.-W.; Liu C.-E.; Chen Y.-H.; Chen Y.-C.; Chuang Y.-C.; SHAN-CHWEN CHANG
國立成功大學 2018 In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) Jean, S.-S.;Lu, M.-C.;Shi, Z.-Y.;Tseng, S.-H.;Wu, T.-S.;Lu, P.-L.;Shao, P.-L.;Ko, W.-C.;Wang, F.-D.;Hsueh, P.-R.
國立成功大學 2018 Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan? Lu, P.-L.;Liu, W.-L.;Lo, H.-J.;Wang, F.-D.;Ko, W.-C.;Hsueh, P.-R.;Ho, M.-W.;Liu, C.-E.;Chen, Y.-H.;Chen, Y.-C.;Chuang, Y.-C.;Chang, S.-C.
國立成功大學 2018 Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan Lai, C.-C.;Lin, Y.-T.;Lin, Y.-T.;Lu, M.-C.;Shi, Z.-Y.;Chen, Y.-S.;Wang, L.-S.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Ko, W.-C.;Wang, F.-D.;Hsueh, P.-R.;Taiwan, Infection Control Society of
臺大學術典藏 2010 Consensus Statement on the Adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in Clinical Microbiology Laboratories in Taiwan Po-Ren Hsueh;Ko W.-C.;Wu J.-J.;Lu J.-J.;Wang F.-D.;Wu H.-Y.;Wu T.-L.;Teng L.-J.; PO-REN HSUEH; Ko W.-C.; Wu J.-J.; Lu J.-J.; Wang F.-D.; Wu H.-Y.; Wu T.-L.; Teng L.-J.

显示项目 31-67 / 67 (共2页)
1 2 > >>
每页显示[10|25|50]项目